| Literature DB >> 35919479 |
Yingjun Qian1, Xinzhong Zang2, Huanzhang Li3, Zhaoyu Guo1, Changhai Zhou1, Menbao Qian1, Yingdan Chen1, Hongkun Liu4, Yuhua Liu4, Shizhu Li1.
Abstract
What is already known about this topic?: Neurocysticercosis is the most severe form of infection caused by ingesting cysticerci, the larval cysts of the pork tapeworm, Taenia solium. Approximately 50 million people worldwide have neurocysticercosis, which is the leading cause of acquired epilepsy in many endemic countries. What is added by this report?: The health of neurocysticercosis patients can be seriously impaired, including through loss of mobility, inability to do self-care, impairment of usual activities, pain/discomfort, anxiety/depression, and impaired cognition. Cognitive impairment is the major consequence of neurocysticercosis and significant contributor to decreased health-related quality of life. Our study made the first estimate of disability weight from neurocysticercosis as a key parameter for disease burden assessment in China. What are the implications for public health practice?: To prevent severe health outcomes from neurocysticercosis in China, it is necessary to improve public awareness of neurocysticercosis and relevant health behaviors. Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022.Entities:
Keywords: hot spots area; neurocysticercosis; quality of life
Year: 2022 PMID: 35919479 PMCID: PMC9339364 DOI: 10.46234/ccdcw2022.134
Source DB: PubMed Journal: China CDC Wkly ISSN: 2096-7071
NCC patients’ 6 health dimensions of health problems.
|
|
|
|
|
|
| |||
|
|
|
| ||||||
| Abbreviation: NCC=neur ocysticercosis.
| ||||||||
| Mobility¶ | 201(95.71) | 9(4.29) | 0(0.00) | 9(4.29) | 5(5.95) | 4(3.17) | >0.05 | |
| Self-care¶ | 204(97.14) | 6(2.86) | 0(0.00) | 6(2.86) | 2(2.38) | 4(3.17) | >0.05 | |
| Daily activities | 124(59.05) | 83(39.52) | 3(1.43) | 86(40.95) | 38(45.24) | 48(38.10) | 1.06 | >0.05 |
| Pain/discomfort | 61(29.05) | 147(70.00) | 2(0.95) | 149(70.95) | 65(77.38) | 84(66.67) | 2.81 | >0.05 |
| Anxiety/depression | 80(38.09) | 118(56.19) | 12(5.71) | 130(61.90) | 53(63.10) | 77(61.11) | 0.03 | >0.05 |
| Cognitive impairment | 59(28.1) | 144(68.57) | 7(3.33) | 151(71.90) | 57(67.86) | 94(74.60) | 1.14 | >0.05 |
| Any dimension¶ | 14(6.67) | 175(83.33) | 21(10.00) | 196(93.33) | 80(95.24) | 116(92.06) | >0.05 | |
Linear regression analysis of factors influencing EQ-VAS score.
|
|
|
|
|
|
|
| Abbreviations: EQ-VAS=European quality of life visual analogue scale; SE=standard error. | |||||
| Intercept | 87.44 | 2.94 | 29.72 | <0.0001 | |
| Age group (years) | |||||
| 15 | −1.39 | 3.47 | −0.40 | >0.05 | −0.05 |
| 30 | −0.33 | 3.43 | −0.10 | >0.05 | −0.01 |
| 45 | −0.09 | 3.48 | −0.03 | >0.05 | 0.00 |
| ≥60 | −3.20 | 3.90 | −0.82 | >0.05 | −0.07 |
| Occupation | 2.62 | 1.56 | 1.68 | >0.05 | 0.10 |
| Mobility | −0.38 | 3.43 | −0.11 | >0.05 | −0.01 |
| Self-care | −6.19 | 4.16 | −1.49 | >0.05 | −0.08 |
| Usual activity | −7.13 | 1.46 | −4.88 | <0.001 | −0.27 |
| Pain/discomfort | −6.97 | 1.50 | −4.66 | <0.001 | −0.25 |
| Anxiety/depression | −5.42 | 1.52 | −3.56 | <0.001 | −0.20 |
| Cognitive impairment | −9.12 | 1.65 | −5.52 | <0.001 | −0.32 |